Cargando…
Melatonin in Alzheimer's disease and other neurodegenerative disorders
Increased oxidative stress and mitochondrial dysfunction have been identified as common pathophysiological phenomena associated with neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD). As the age-related decline in the...
Autores principales: | Srinivasan, V, Pandi-Perumal, SR, Cardinali, DP, Poeggeler, B, Hardeland, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483829/ https://www.ncbi.nlm.nih.gov/pubmed/16674804 http://dx.doi.org/10.1186/1744-9081-2-15 |
Ejemplares similares
-
Melatonin, immune function and aging
por: Srinivasan, V, et al.
Publicado: (2005) -
Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug
por: Hardeland, Rüdiger, et al.
Publicado: (2005) -
Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010) -
Melatonin in Mitochondrial Dysfunction and Related Disorders
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2011) -
Possible Application of Melatonin in Long COVID
por: Cardinali, Daniel P., et al.
Publicado: (2022)